Zinc Carnosine
Last reviewed
Zinc Carnosine is a unique 1:1 chelate of zinc and L-carnosine that adheres to the gut lining. It has the strongest human evidence of any supplement for protecting intestinal permeability, while also providing direct mast cell stabilization in the GI tract where MCAS symptoms often start. ZebraThrive uses 75 mg daily, split 37.5 mg AM and PM.
At a Glance
Daily Dose
75 mg daily
Key Benefits
How It Works
Zinc carnosine increases tight junction proteins (occludin) and induces heat shock proteins (HSP70) to protect the gut lining from stress. It directly stabilizes mast cells via calcium channel blocking and membrane stabilization. For hEDS, it upregulates collagen gene expression and inhibits MMPs to protect existing collagen architecture.
What the Research Shows
Strong human RCT evidence for protecting intestinal permeability from various stresses.
Addressing the Triad
Tailored benefits for complex conditions
Zinc carnosine stabilizes mast cells through two complementary mechanisms in lab studies. The zinc half stabilizes mast cell membranes and reduces calcium-ionophore-induced degranulation by around 75% - zinc directly competes for the calcium channels that trigger mast cell release. The carnosine half contributes antioxidant activity that reduces oxidative-stress-induced degranulation. The combined effect is broader than either component alone. The gut barrier work also matters for MCAS specifically: a leaky gut accelerates food-protein and bacterial-fragment translocation that drives mast cell activation in many MCAS patients. Protecting the gut barrier reduces upstream mast cell triggers.
Zinc carnosine's hEDS relevance is mostly the gut barrier story, but with a twist worth knowing. Many hEDS patients have higher rates of intestinal permeability ('leaky gut') that can drive systemic inflammation - and chronic systemic inflammation amplifies MMP expression in connective tissue. Reducing gut-driven inflammation can quiet that loop. At our 75 mg/day dose, MMP-1 and MMP-13 (the actual collagen-degrading enzymes elevated in hEDS) are unaffected based on the available data. The 150 mg/day study in fibrotic liver isn't a useful comparison for our non-fibrotic population at half that dose.
For POTS, zinc carnosine's role is mostly indirect, working through the gut-autonomic axis. Many POTS patients have GI symptoms (gastroparesis, post-meal palpitations, IBS-like patterns) that interact with autonomic dysregulation in both directions. The gut barrier protection from zinc carnosine - stabilizing tight junctions and reducing intestinal permeability - addresses one upstream contributor to the inflammatory cascade that feeds autonomic instability. Zinc carnosine isn't a primary POTS intervention; it's gut maintenance that supports the autonomic system indirectly. The 12-hour split between zinc and copper in our formulation avoids absorption competition.
Why We Chose This Form
We use generic zinc carnosine specified as a 1:1 zinc-to-carnosine molar chelate (verifiable by Certificate of Analysis on every lot). The 1:1 molar ratio is the structural feature responsible for the gut barrier and mast cell mechanisms - not a brand-specific advantage. We dose 37.5 mg twice daily (AM and PM), not 75 mg once daily, because the human RCTs that established efficacy all used split BID dosing - the mucosal coating mechanism requires repeated administration. Take with or just before meals for optimal local contact with the gut lining.
Form Comparison
Polaprezinc
Stable 1:1 chelate; 2x longer mucosal contact; targeted action
Zinc + L-Carnosine separately
Lacks mucosal targeting; faster gastric transit
Safety & Interactions
Potential Side Effects
Excellent safety record (30+ years prescription use). Mild nausea possible but rare.
Drug Interactions
AVOID with Warfarin (reports of increased INR). Separate from fluoroquinolones, tetracyclines, and iron by 4-6 hours.
Excipients to Avoid
- Iron competition
Safe Excipients
- HPMC capsules
- Rice flour
Monitor copper status if supplementing long-term above 40mg total zinc.
How to Start
| Protocol Step | Suggested Dosage | Key Notes |
|---|---|---|
| Week 1 | 37.5 mg daily | Check GI tolerance |
| Week 2+ | 75 mg daily | Target dose (PM) |
"GI barrier benefits within 2-14 days; structural improvement noticeably at 4-8 weeks."
State of the Evidence
No direct clinical trials in hEDS, POTS, or MCAS populations. Most data extrapolated from athletic, NSAID-user, and gastric ulcer populations.
- [1]Zinc carnosine for gut permeability RCTPMID: 16777920
Mahmood et al. (2007)
- [2]Exercise-induced gut barrier protection RCTPMID: 27357095
Davison et al. (2016)
- [3]Zinc carnosine mast cell stabilizationPMID: 1943472
Cho et al. (1991)
- [4]Anti-inflammatory effects in human mast cellsPMID: 30521103
Gross et al. (2019)
- [5]HSP70 induction by zinc carnosinePMID: 12498304
Odashima et al. (2002)
Common Questions
Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .